Scientists compare heart drugs warfarin and rivaroxaban
Most Americans are concerned about maintaining good heart health, which is why many of them buy Lipitor to reduce their risk of experiencing a heart attack or developing high cholesterol.
Most Americans are concerned about maintaining good heart health, which is why many of them buy Lipitor to reduce their risk of experiencing a heart attack or developing high cholesterol. Millions of individuals suffer from heartbeat irregularities, which could be addressed with a recently developed drug that is easier to administer, according to British researchers from the University of Edinburgh.
Together with a team of scientists from Duke University in North Carolina, the group studied the effects of a standard treatment called warfarin with those of a new medication known as rivaroxaban.
Both products were found to be equally effective, but rivaroxaban did not need to be as closely monitored. Warfarin can be a tricky drug to adminster because it is easily affected by the patient's diet or other drugs.
"Warfarin has been a standard treatment for decades, but requires a rigorous monitoring schedule to ensure therapeutic dosing levels, and is subject to the potential of food and drug interactions that present treatment obstacles for patients and doctors alike," the researchers explained. "The results of this large global trial have convincingly shown rivaroxaban to be an alternative to warfarin in treating patients with atrial fibrillation and, importantly, with no increase in bleeding."
|
